Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2946742 | 1.00 | KDM4E (0.41) | KDM4EL3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL2942363 | 0.82 | TSHR (0.45) | KDM4EL3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL2942362 | 0.82 | TSHR (0.45) | KDM4EL3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL7384750 | 0.81 | KDM4E (0.52) | KDM4EL3MBTL1TSHRKMT2APIK3CD | |
| SCHEMBL6893049 | 0.80 | ALDH1A1 (0.37) | ALDH1A1SMN1; SMN2BRD4TP53GAA | |
| SCHEMBL6893054 | 0.80 | ALDH1A1 (0.37) | ALDH1A1SMN1; SMN2BRD4TP53GAA | |
| SCHEMBL13745122 | 0.77 | KDM4E (0.47) | KDM4EL3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL22340247 | 0.77 | KDM4E (0.47) | KDM4EL3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL26114095 | 0.77 | TP53 (0.41) | KDM4EALDH1A1SMN1; SMN2BRD4TP53 | |
| SCHEMBL14835319 | 0.76 | L3MBTL1 (0.48) | KDM4EL3MBTL1TSHRKMT2APIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1489078-B1 | BENZOFURAN DERIVATIVE | MITSUBISHI TANABE PHARMA CORP (JP) | 2010-01-06 | — | — | EP | disclosed |
| US-20090209511-A1 | Benzofuran Derivatives | KAWAGUCHI TAKAYUKI | 2009-08-20 | — | — | US | disclosed |
| US-7531537-B2 | Benzofuran derivative | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-05-12 | — | — | US | disclosed |
| US-20050282808-A1 | Benzofuran derivative | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2005-12-22 | — | — | US | disclosed |
| EP-1489078-A1 | BENZOFURAN DERIVATIVE | Tanabe Seiyaku Co., Ltd. (JP) | 2004-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282808-A1 | Benzofuran derivative | F12, F2, F11 | KDM4E 1427/4885L3MBTL1 4087/4885ALDH1A1 683/4885 |
| US-20090209511-A1 | Benzofuran Derivatives | F12, F2, F3 | KDM4E 1464/4885L3MBTL1 4101/4885ALDH1A1 693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.